BrokerLens

Sotac Pharmaceuticals Limited IPO (SOTAC)

Status
Listed
Security type
SME
Price band
Rs.105 to Rs.111
Final issue price
Rs 111
Issue size
Not disclosed
Bidding opens
29 March 2023
Bidding closes
3 April 2023
Listing date
13 April 2023

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Sotac Pharmaceuticals Limited IPO?

The Sotac Pharmaceuticals Limited IPO price band is Rs.105 to Rs.111 per share.

When does the Sotac Pharmaceuticals Limited IPO open and close?

Bidding opens 29 March 2023 and closes 3 April 2023.

Is the Sotac Pharmaceuticals Limited IPO a mainboard or SME issue?

Sotac Pharmaceuticals Limited is an SME IPO, listing on NSE Emerge.

When did the Sotac Pharmaceuticals Limited IPO list?

Sotac Pharmaceuticals Limited listed on 13 April 2023.

Does this page show the grey market premium (GMP) for Sotac Pharmaceuticals Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Sotac Pharmaceuticals Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.